Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes (Tables)

v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Current and Deferred Components of Income Tax Expense (Benefit)
The table below presents the current and deferred components of income tax expense (benefit) for the following periods:
Year Ended
December 31, 2024 December 31, 2023
Current:
Federal $ —  $ — 
State 67  (73)
Foreign (284) 512 
Total current income tax expense (benefit) (217) 439 
Deferred:
Federal (122) 48 
State 271  62 
Foreign (1,952) (1,035)
Total deferred income tax expense (benefit) (1,803) (925)
Total income tax expense (benefit) $ (2,020) $ (486)
Schedule of Effective Income Tax Rate
A reconciliation of the U.S. federal statutory income tax expense to actual income tax expense is as follows:
Year Ended
December 31, 2024 December 31, 2023
Income (loss) before income taxes $ (116,331) $ (27,750)
Federal statutory income tax rate 21.0  % 21.0  %
Expected federal provision (benefit) for income taxes at the federal statutory income tax rate (24,430) (5,828)
State income tax (benefit), net of federal tax benefit (3,159) (1,190)
Change in fair value of warrants 10,912  422 
Permanent differences 314  136 
Tax (benefits) / non-deductible expenses related to equity-based compensation (636) 984 
Acquisition costs 219  — 
Change in valuation allowance 16,153  4,808 
Other (1,393) 182 
Total income tax expense (benefit)
$ (2,020) $ (486)
Effective tax rate 1.7  % 1.8  %
Schedule of Deferred Tax Assets and Liabilities
The table below presents the components of deferred tax assets, net and deferred tax liabilities:
December 31, 2024 December 31, 2023
Deferred tax assets:
Accrued expenses and reserves $ 456  $ 1,992 
Capitalized research and development expenses 4,528  2,241 
Tax credit carryforwards 243  240 
Deferred revenue 1,367  1,217 
Net operating loss carryforwards 38,676  20,371 
Interest disallowance 10,007  6,640 
Equity-based compensation 2,643  1,580 
Lease liability 4,956  4,454 
Other assets 62  54 
Total deferred tax assets 62,938  38,789 
Less: valuation allowance (45,324) (23,821)
Deferred tax assets, net of valuation allowance 17,614  14,968 
Deferred tax liabilities:
Right-of-use asset $ (4,291) $ (3,725)
Depreciation and amortization (13,616) (13,523)
Other (217) (122)
Deferred tax liabilities (18,124) (17,370)
Total net deferred tax assets (liabilities) $ (510) $ (2,402)
Schedule of Change in Valuation Allowance
The table below presents the change in valuation allowance for the following periods:
Valuation allowance as of December 31, 2022 $ (19,013)
Income tax expense (4,808)
Valuation allowance as of December 31, 2023
$ (23,821)
Acquired deferred tax assets
(5,350)
Income tax expense (16,153)
Valuation allowance as of December 31, 2024
$ (45,324)
Schedule of Unrecognized Tax Benefits
The table below presents changes in reserves for unrecognized income tax benefits for the following periods:
Year Ended
December 31, 2024 December 31, 2023
Unrecognized tax benefits, beginning of period $ 1,380  $ 1,380 
Increase (decrease) for tax positions taken related to a prior period —  — 
Unrecognized tax benefits, end of period $ 1,380  $ 1,380